David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 900 shares at $1.64 ($1K) on 2018-09-05, disclosed to the SEC on 2018-09-07.
Scheduled sale ($1k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.64 | 27 | $44 | 3.0% |
| 2 | $1.64 | 59 | $97 | 6.6% |
| 3 | $1.64 | 814 | $1K | 90.4% |
| Total | $1.64 avg | 900 | $1K | 100% |
| Filing → |
| GEN | SELL | 2018-11-15 | $53K | — | Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |